Contact Boris

Speaking Engagements

  

Welcome to the Optimizing AAV Safety Summit: Predict & Monitor AAV Safety Signals to De-Risk Genetic Therapy Development Hundreds of clinical trials using AAV are underway, with several hundred more in preclinical development.

06-08 September 2022
  

CHI is excited to host its 14th Annual Immunogenicity & Bioassay Summit – a “Live” In-Person & Virtual event. We’ll examine challenges facing the industry with NEW case studies, NEW perspectives and NEW approaches.

03-06 October 2022
  

The 3rd Annual Gene Therapy Immunogenicity Summit is industry’s definitive forum enabling you to better modulate, measure and predict the immune response to your gene therapy candidate.

18-20 October 2022
  

This year's Immunogenicity Summit brings the FDA together with leading industry and academic experts to discuss the development, application and validation of immunogenicity assays. Learn how to manage drug and target interference and tolerance, understand the impact of pre-existing antibodies and interpret the clinical significance of assay data.

03-04 October 2023